iiinova — where your digital self keeps evolving

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 29/09/2026

Takayasu's arteritis is rare and balloon angioplasty can help improve survival. Read this cohort study to understand more about how this advanced center manages their patient population. journals.sagepub.com/doi/10.1177/.... @ild-ipfdoc.bsky.social

032

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 15/09/2026

Congratulations to our Editorial Review Board member Maria Koulopoulou on presenting at #ERSCongress2026, with work focused on developing a competency framework for specialist ILD healthcare practitioners. #ILD #RespiratoryCare #RespiratoryResearch

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/09/2026

Presented by our Editorial Review Board member Guilherme Rodrigues at #ERSCongress2026, this poster explored inhaled therapy changes following COPD exacerbations in primary care. Check it out👇 #COPD #RespiratoryResearch #PrimaryCare #ERSCongress2026

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/09/2026

Another excellent poster from #ERSCongress2026, presented by our Editorial Review Board member Umberto Zanini, exploring factors associated with steroid responsiveness and clinical outcomes in hypersensitivity pneumonitis. #HypersensitivityPneumonitis #RespiratoryMedicine

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/09/2026

Exciting to see one of our published articles showcased on the main stage at #ERSCongress2026 today! "Treatable traits in interstitial lung disease: a narrative review" 🔗https://doi.org/10.1177/17534666251335774 #ERSCongress2026 #ILD #RespiratoryResearch

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/09/2026

Great to see our Associate Editor Min Xie presenting two posters on lymphangioleiomyomatosis (LAM) at #ERSCongress2026, contributing to ongoing research into this rare lung disease. #ERSCongress2026 #RespiratoryResearch #LAM

111

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/09/2026

An important poster presented at #ERSCongress2026 by our Editorial Review Board member Maria Koulopoulou, examining the impact of early structured triage on access to pulmonary rehabilitation services and waiting times. #RespiratoryMedicine #PulmonaryRehabilitation

012

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/09/2026

Great to see our Editorial Review Board member Ahmed Kabil presenting at #ERSCongress2026 on the value of the sinusoid sign in predicting trapped lung in patients with malignant pleural effusion. #RespiratoryResearch

012

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 07/09/2026

Another fantastic day at #ERSCongress2026 attending sessions, exploring posters, and meeting Editorial Board members at today's drop-in. Looking forward to another great day tomorrow, including our next Editorial Board meetup. #RespiratoryResearch

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 06/09/2026

Fascinating research presented by one of our Editorial Review Board members, Ilias Dimeas, at #ERSCongress2026 examining respiratory microplastic burden in patients with lung malignancy. #RespiratoryResearch #LungCancer #ERS2026

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 06/09/2026

A great poster from the TAR community at #ERSCongress2026, exploring eligibility for type 2 biologic therapy in COPD. Congratulations to Prof. Antonio Spanevello, Marco Vanetti, and colleagues. #COPD #RespiratoryResearch

111

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 06/09/2026

Great to be at #ERSCongress2026 this morning! Already spotted some fantastic posters showcasing respiratory research across the world! Keep an eye on our feed as we’ll be sharing photos of posters presented by members of our Editorial Board throughout the congress! #Respiratory

021

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 04/09/2026

✈️ We're heading to #ERSCongress2026 tomorrow! Looking forward to connecting with the respiratory community, meeting our editors and authors, and hearing about the latest advances in respiratory research. @europeanrespsoc.bsky.social

121

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 23/08/2026

This study examines 4 lung derived COPD associated candidate genes through integrative transcriptomics - read the full paper to see which ones appear to have high diagnostic potential. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 19/08/2026

Read our latest paper - this 21-year retrospective study looks at the efficacy of bronchoscopic resection for endobronchial hamartomas and leiomyomas. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 21/07/2026

Microplastics are all around us (and in us!). Read this systematic review on what the evidence says about their effects on the lungs. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

022

Reposted by Therapeutic Advances in Respiratory Disease

WHO @who.int · 20/07/2026

Want better sleep? 😴 Let your body wind down and give your mind a break from screens, including TVs, computers and smartphones, before bedtime.

4748

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 02/07/2026

Sarcoidosis is a multisystemic disease with varied presentations. Read this latest paper phenotypic sarcoidosis through cluster analysis. journals.sagepub.com/doi/10.1177/...

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 08/06/2026

Read this physiological study on the hemodynamics profiles of arterial stiffness and wave reflection in patients with asthma. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 22/05/2026

Cough variant asthma can be tricky to diagnose. Read this latest article on the excellent performance of a clinical prediction model to identify this condition. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

021

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 22/04/2026

Pulmonary Arterial Hypertension (PAH) can be more challenging to manage than most providers realize. Read this narrative review describing the many barriers to patient centered care in PAH. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

011

Reposted by Therapeutic Advances in Respiratory Disease

WHO @who.int · 07/04/2026

What if doctors could see inside your body without ever making a cut? Science made it real. X-ray, CT scan, MRI and ultrasound! Today these non-invasive visualizations of our bodies are a lifesaver. This #WorldHealthDay: Together for Health #StandWithScience 💙

Seeing inside your body without ever making a cut? Science made it possible.

Together for health, stand with science.

Image shows a health worker holding up a scan, with an illustrative line wrapping around the frame.

18715

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 03/04/2026

Many genetic disorders can result in a spontaneous pneumothorax. Read this review article published on these rare conditions that can present with spontaneous pneumothorax. journals.sagepub.com/doi/10.1177/.... @ild-ipfdoc.bsky.social

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 23/03/2026

Patients with ILD may need oxygen therapy when traveling on a flight. The hypoxic challenge test is not always available. Read this latest study exploring an algorithm to predict oxygen requirement for patients who may be traveling. @ild-ipfdoc.bsky.social journals.sagepub.com/doi/10.1177/....

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 12/03/2026

Biologics have transformed the management of severe persistent asthma. Read the latest article on our journal about biomarkers that help with agent selection. journals.sagepub.com/doi/10.1177/.... @ild-ipfdoc.bsky.social

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 03/03/2026

Read this novel study investigating an AI based tele rehabilitation app that enhanced access to pulmonary rehab in patients recovering from lung cancer surgery. journals.sagepub.com/doi/10.1177/... @ild-ipfdoc.bsky.social

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 27/02/2026

Does noninvasive ventilation during pulmonary rehabilitation help improve patient outcomes? Read our latest article to find out! journals.sagepub.com/doi/10.1177/...

011

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · 17/10/2025

Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT @tarespirdis.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #NSCLC #radiomics #medicalimaging #precisiononcology #openaccess

001

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 30/09/2025

Lungs on fire 🔥 - the ERS session on respiratory infections is about to kick off. Looking forward to insights from Associate Editor Tom Wilkinson, who's joining as a discussant. #ERSCongress2025 #ERS2025 #RespiratoryHealth

010

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 30/09/2025

Later today Associate Editor Corrado Pelaia is chairing a session at #ERS2025: Remission/stability in airway diseases – how to achieve it and what’s next? Exploring strategies for long-term disease control and emerging research. #ERSCongress2025 #AirwayDiseases

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 30/09/2025

At #ERS2025, Associate Editor Dr Shaney Barratt chaired a poster session on Clinical prognostication in pulmonary fibrosis. The session highlighted current approaches and future directions in predicting disease progression. #ERSCongress2025 #PulmonaryFibrosis

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 30/09/2025

Great to connect with Editor-in-Chief Dr. Nazia Chaudhuri and several Associate Editors of Therapeutic Advances in Respiratory Disease at #ERSCongress2025 yesterday. Valuable discussions around editorial priorities and future plans! #ERS2025 #RespiratoryDisease @ild-ipfdoc.bsky.social

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 29/09/2025

🔥 Lungs on Fire: Interstitial Lung Diseases is now live at #ERS2025 - a packed session co-chaired by our Editor-in-Chief, Dr Nazia Chaudhuri. #ERSCongress

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 29/09/2025

📣Just published: a plain language summary of publication exploring how doctors and patients communicate about treatment for systemic sclerosis-associated interstitial lung disease. 👉Read it here: journals.sagepub.com/doi/full/10.... #SSc #ILD

journals.sagepub.com

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 29/09/2025

It's our second day at #ERS2025! Today’s programme includes sessions chaired by our Associate Editors and Editor-in-Chief. Looking forward to the discussions ahead. #ERSCongress

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 28/09/2025

📢About to begin: ALERT 2 – Infections, Lung Cancer and Respiratory Symptoms Management Chaired by our Associate Editor Tom Wilkinson, with editorial board member Francesco Blasi joining as a discussant. Looking forward to catching some of the insights!🫁 #ERSCongress2025

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 28/09/2025

Enjoyed the session on Emerging Clinical Trials in Pulmonary Fibrosis, co-chaired by our Editor-in-Chief Dr. Nazia Chaudhuri. A popular and timely discussion with lots of interest from attendees. #ERS2025 #ERSCongress2025 #ClinicalTrials

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 28/09/2025

Great turnout at ALERT 1: Obstructive Airway Diseases in Children and Adults, with our Associate Editor Prof Antonio Spanevello contributing as a discussant. Engaging presentations and valuable discussion made this a great session🫁 #ERS2025 #RespiratoryMedicine #ERSCongress

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 28/09/2025

📍#ERSCongress Check out this fascinating abstract: “Mepolizumab induces proteome changes in eosinophils from severe eosinophilic asthma” - coauthored by our editorial board member Francisco-Javier Gonzalez-Barcala. #ERS2025 #Asthma

000

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 28/09/2025

Excited to be at #ERSCongress today! Looking forward to sharing highlights from sessions and posters - including some fantastic contributions from our board. Stay tuned for updates throughout the day 🫁✨ #ERS2025 #RespiratoryMedicine

020

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 22/09/2025

📍 Heading to Amsterdam for #ERSCongress this week! Looking forward to connecting with our Editorial Board Members and engaging with the latest developments in respiratory research. If you're attending, feel free to get in touch! Follow along for updates from the congress! 🫁

000

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · 20/06/2025

The correlation between the level of therapy adherence and inhalation technique in children with uncontrolled asthma using a smart inhaler: the IMAGINE study @tarespirdis.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #ehealth #pediatric #medicine #medsky #openaccess

001

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · 20/06/2025

Efficacy of respiratory muscle training in improving pulmonary function and survival in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis @tarespirdis.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #ALS #neuromuscular #healthcare #openaccess

001

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · 27/06/2025

Therapeutic options for patients with pulmonary hypertension and interstitial lung disease @tarespirdis.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #respiratorydisease #treatment #medicine #medsky #openaccess

063

Reposted by Therapeutic Advances in Respiratory Disease

Jen L, PhD @drjkyl.bsky.social · 12/09/2025

Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine @tarespirdis.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #artificialintelligence #genetictesting #medsky #lungdisease #openaccess

011

Therapeutic Advances in Respiratory Disease @tarespirdis.bsky.social · 09/05/2025

Immunosuppression is a core part of managing interstitial lung diseases. Learn how outcomes differ between antisynthetase syndrome and systemic sclerosis in response to treatment! journals.sagepub.com/doi/full/10....

011